Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
暂无分享,去创建一个
P. Ditonno | M. Battaglia | M. Rutigliano | F. Crocetto | G. Lucarelli | S. D. Pandolfo | Martina Milella | S. Pandolfo | Francesco Lasorsa | Matteo Ferro | Loreto Gesualdo | Simona Simone
[1] J. Thurman,et al. The role of complement in kidney disease , 2023, Nature Reviews Nephrology.
[2] J. Lv,et al. Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy , 2023, Clinical journal of the American Society of Nephrology : CJASN.
[3] P. Ditonno,et al. Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers , 2023, International journal of molecular sciences.
[4] G. Choukroun,et al. Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease , 2023, Frontiers in immunology.
[5] N. Sheerin,et al. Complement activation and kidney transplantation; a complex relationship. , 2023, Immunobiology.
[6] P. Ditonno,et al. Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma , 2023, Journal of clinical medicine.
[7] Benjamin Wooden,et al. Complement inhibitors for kidney disease. , 2023, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] M. Coughlan,et al. Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease , 2023, International journal of molecular sciences.
[9] Parul Singh,et al. Complement, complosome, and complotype: A perspective , 2023, European journal of immunology.
[10] C. Kemper,et al. Complosome — the intracellular complement system , 2023, Nature Reviews Nephrology.
[11] P. Ditonno,et al. Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice , 2023, Biomedicines.
[12] P. Ditonno,et al. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery , 2023, Expert review of molecular diagnostics.
[13] Songqing He,et al. The role of the complosome in health and disease , 2023, Frontiers in Immunology.
[14] D. Ribatti,et al. MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation , 2023, International journal of molecular sciences.
[15] M. López-Nevot,et al. Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation , 2023, Journal of clinical medicine.
[16] S. Aiello,et al. The Complement System in Kidney Transplantation , 2023, Cells.
[17] M. Säemann,et al. Novel aspects in the pathophysiology and diagnosis of glomerular diseases , 2022, Annals of the Rheumatic Diseases.
[18] C. Daniel,et al. Complement Inhibition in Kidney Transplantation: Where Are We Now? , 2022, BioDrugs.
[19] P. Ditonno,et al. Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets , 2022, International journal of molecular sciences.
[20] P. Ditonno,et al. MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome , 2022, International journal of molecular sciences.
[21] Yan-jun Zhu,et al. Alternative Complement Pathway Signature Determines Immunosuppression and Resistance to Immunotherapy Plus Tyrosine Kinase Inhibitor Combinations in Renal Cell Carcinoma. , 2022, Urologic oncology.
[22] G. Strada,et al. The cross‐talk between Abl2 tyrosine kinase and TGFβ1 signalling modulates the invasion of clear cell Renal Cell Carcinoma cells , 2022, FEBS letters.
[23] A. Bagga,et al. Haemolytic uraemic syndrome , 2022, The Lancet.
[24] A. Blom,et al. Intracellular complement: Evidence, definitions, controversies, and solutions , 2022, Immunological reviews.
[25] F. Bray,et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. , 2022, European urology.
[26] M. Kolev,et al. Inside-Out of Complement in Cancer , 2022, Frontiers in Immunology.
[27] P. Lund,et al. Alternative splicing encodes functional intracellular CD59 isoforms that mediate insulin secretion and are down-regulated in diabetic islets , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Reinhard,et al. Membranous nephropathy: new pathogenic mechanisms and their clinical implications , 2022, Nature Reviews Nephrology.
[29] Beata Franczyk,et al. Renal Cell Cancer and Obesity , 2022, International journal of molecular sciences.
[30] Weijun Qin,et al. Role of Complement System in Kidney Transplantation: Stepping From Animal Models to Clinical Application , 2022, Frontiers in Immunology.
[31] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[32] G. Giardino,et al. Inherited defects in the complement system , 2022, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[33] M. Ruseva,et al. Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation , 2021, Science Immunology.
[34] S. Wen,et al. Intracellular C3 prevents hepatic steatosis by promoting autophagy and very‐low‐density lipoprotein secretion , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] H. Jägle,et al. Complement Factor H-Related 3 Enhanced Inflammation and Complement Activation in Human RPE Cells , 2021, Frontiers in Immunology.
[36] Weimin Ma,et al. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma , 2021, BMC Cancer.
[37] Sarah E. Street,et al. Renal Cell Cancer and Chronic Kidney Disease. , 2021, Advances in chronic kidney disease.
[38] M. Pickering,et al. Complement activation in IgA nephropathy , 2021, Seminars in Immunopathology.
[39] S. Neelamegham,et al. Local Complement Factor H protects kidney endothelial cell structure and function. , 2021, Kidney international.
[40] Yung-Ming Chen,et al. Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients , 2021, Frontiers in Immunology.
[41] P. Ditonno,et al. Novel Insights into the Molecular Mechanisms of Ischemia/Reperfusion Injury in Kidney Transplantation , 2021, Transplantology.
[42] P. Validire,et al. Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade , 2021, Cancer Immunology Research.
[43] P. Validire,et al. Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s , 2021, Cancer Immunology Research.
[44] L. Gesualdo,et al. Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury , 2021, Aging.
[45] G. Beeson,et al. Mitochondrial C3a Receptor Activation in Oxidatively Stressed Epithelial Cells Reduces Mitochondrial Respiration and Metabolism , 2021, Frontiers in Immunology.
[46] Chunhua Huang,et al. CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer , 2021, Molecular therapy. Nucleic acids.
[47] D. Portilla,et al. Role of intracellular complement activation in kidney fibrosis , 2021, British journal of pharmacology.
[48] H. Debiec,et al. Advances in Membranous Nephropathy , 2021, Journal of clinical medicine.
[49] C. Porta,et al. Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma , 2020, Metabolites.
[50] J. Brugarolas,et al. Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma , 2020, The Journal of Immunology.
[51] C. Sautès-Fridman,et al. Complement System: Promoter or Suppressor of Cancer Progression? , 2020, Antibodies.
[52] M. Accetturo,et al. DelCFHR3‐1 influences graft survival in transplant patients with IgA nephropathy via complement‐mediated cellular senescence , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[53] J. Pascual,et al. Activation of final complement components after kidney transplantation as a marker of delayed graft function severity , 2020, Clinical kidney journal.
[54] N. Merle,et al. Complement's favourite organelle—Mitochondria? , 2020, British Journal of Pharmacology.
[55] G. Bovo,et al. 36 kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in clear cell Renal Cell Carcinoma Cells. , 2020, The American journal of pathology.
[56] H. Lee,et al. Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis , 2020, Lupus.
[57] L. Gesualdo,et al. PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma , 2020, Aging.
[58] C. Viret,et al. Regulation of anti-microbial autophagy by factors of the complement system , 2020, Microbial cell.
[59] J. Thurman. Complement and the Kidney: An Overview. , 2020, Advances in chronic kidney disease.
[60] S. Kulkarni,et al. Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[61] P. Zipfel,et al. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. , 2020, Journal of the American Society of Nephrology : JASN.
[62] C. Shu,et al. C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts , 2020, Journal of Experimental & Clinical Cancer Research.
[63] S. Jordan,et al. Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients. , 2019, Clinical journal of the American Society of Nephrology : CJASN.
[64] J. Cesbron,et al. The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease , 2019, Clinical Reviews in Allergy & Immunology.
[65] P. Cravedi,et al. Complement and Complement Targeting Therapies in Glomerular Diseases , 2019, International journal of molecular sciences.
[66] Yupei Zhao,et al. Role of the complement system in the tumor microenvironment , 2019, Cancer Cell International.
[67] I. Maillard,et al. Notch signalling in T cell homeostasis and differentiation , 2019, Open Biology.
[68] A. Hakimi,et al. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma. , 2019, Cancer discovery.
[69] C. Sautès-Fridman,et al. Context-dependent roles of complement in cancer , 2019, Nature Reviews Cancer.
[70] P. Sansonetti,et al. 100th Anniversary of Jules Bordet's Nobel Prize: Tribute to a Founding Father of Immunology , 2019, Front. Immunol..
[71] L. Gesualdo,et al. Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury , 2019, Aging.
[72] Kun-yi Wu,et al. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury. , 2019, Kidney international.
[73] A. Pircher,et al. Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy , 2019, Front. Oncol..
[74] P. Validire,et al. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth , 2019, Cancer Immunology Research.
[75] D. Ribatti,et al. Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment. , 2019, Urologic oncology.
[76] A. Blom,et al. Interaction of Serum-Derived and Internalized C3 With DNA in Human B Cells—A Potential Involvement in Regulation of Gene Transcription , 2019, Front. Immunol..
[77] A. Blom,et al. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment. , 2019, JCI insight.
[78] P. Garred,et al. Expression of complement C3, C5, C3aR and C5aR1 genes in resting and activated CD4+ T cells. , 2019, Immunobiology.
[79] A. Blom,et al. Intracellular cytosolic complement component C3 regulates cytoprotective autophagy in pancreatic beta cells by interaction with ATG16L1 , 2019, Autophagy.
[80] Y. Wan,et al. Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages , 2018, Cancer Immunology Research.
[81] D. Ribatti,et al. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma , 2018, Aging.
[82] M. Haas,et al. A phase I/II, double‐blind, placebo‐controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[83] Jan U. Becker,et al. A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology , 2018, Transplantation.
[84] M. Pirooznia,et al. Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism , 2018, Nature Communications.
[85] Adam A. Margolin,et al. Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy. , 2018, Cancer cell.
[86] P. Ditonno,et al. The urea cycle enzymes act as metabolic suppressors in clear cell renal cell carcinoma , 2018, Translational Cancer Research.
[87] M. Markiewski,et al. Complementing Cancer Metastasis , 2018, Front. Immunol..
[88] L. Gesualdo,et al. Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling , 2018, Front. Immunol..
[89] D. Philpott,et al. Complement C3 Drives Autophagy-Dependent Restriction of Cyto-invasive Bacteria. , 2018, Cell host & microbe.
[90] M. Kolev,et al. Complement and the Regulation of T Cell Responses. , 2018, Annual review of immunology.
[91] C. Garlanda,et al. PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer. , 2018, Physiological reviews.
[92] O. Dymova,et al. A prospective randomized, controlled trial of eculizumab to prevent ischemia‐reperfusion injury in pediatric kidney transplantation , 2018, Pediatric transplantation.
[93] Z. Fishelson,et al. Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9 , 2018, Cell Death & Disease.
[94] R. Weiss,et al. The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation , 2017, Oncotarget.
[95] R. Pio,et al. Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment. , 2017, Seminars in cell & developmental biology.
[96] C. Farrar,et al. Complement Recognition Pathways in Renal Transplantation. , 2017, Journal of the American Society of Nephrology : JASN.
[97] Dirk Sieger,et al. Complement as a regulator of adaptive immunity , 2017, Seminars in Immunopathology.
[98] P. van Paassen,et al. Complement in ANCA-associated glomerulonephritis , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[99] E. Salvaris,et al. Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice , 2017, The Journal of Immunology.
[100] L. Trouw,et al. Production of complement components by cells of the immune system , 2017, Clinical and experimental immunology.
[101] J. Atkinson,et al. A C3(H20) recycling pathway is a component of the intracellular complement system , 2017, The Journal of clinical investigation.
[102] V. Afshar-Kharghan. The role of the complement system in cancer , 2017, The Journal of clinical investigation.
[103] Ming-hui Zhao,et al. Complement Alternative Pathway's Activation in Patients With Lupus Nephritis , 2017, The American journal of the medical sciences.
[104] Wei Zhang,et al. CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance , 2016, Stem cell reports.
[105] C. Hess,et al. Complement-Mediated Regulation of Metabolism and Basic Cellular Processes. , 2016, Immunity.
[106] M. Battaglia,et al. Multi-omics approach reveals the secrets of metabolism of clear cell—renal cell carcinoma , 2016, Translational andrology and urology.
[107] A. Sher,et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells , 2016, Science.
[108] Wuding Zhou,et al. Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury. , 2016, The Journal of clinical investigation.
[109] Charles H. Yoon,et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.
[110] S. Gandini,et al. Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis , 2016, Nature Communications.
[111] G. Ardissino,et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. , 2016, Kidney international.
[112] G. Remuzzi,et al. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. , 2016, Molecular immunology.
[113] A. Sood,et al. Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial–Mesenchymal Transition , 2016, The Journal of Immunology.
[114] Xian Shen,et al. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition. , 2016, Experimental and molecular pathology.
[115] F. Schena,et al. Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics , 2016, Diseases.
[116] M. Accetturo,et al. Complement Modulation of Anti‐Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[117] J. Thurman,et al. The Complement System and Antibody-Mediated Transplant Rejection , 2015, The Journal of Immunology.
[118] D. Ribatti,et al. Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma , 2015, Medicine.
[119] C. Legendre,et al. The emerging role of complement inhibitors in transplantation. , 2015, Kidney international.
[120] M. Salvadori,et al. Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. , 2015, World journal of transplantation.
[121] M. Kolev,et al. Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses , 2015, Immunity.
[122] V. Frémeaux-Bacchi,et al. Complement System Part I – Molecular Mechanisms of Activation and Regulation , 2015, Front. Immunol..
[123] Lubka T. Roumenina,et al. Complement System Part II: Role in Immunity , 2015, Front. Immunol..
[124] D. Ribatti,et al. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma , 2015, Oncotarget.
[125] Y. Kawano,et al. C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways. , 2015, Oncology reports.
[126] J. Atkinson,et al. Complement regulators in human disease: lessons from modern genetics , 2015, Journal of internal medicine.
[127] M. Battaglia,et al. The Role of Renal Surgery in the Era of Targeted Therapy: The Urologist's Perspective , 2015, Urologia.
[128] John D Lambris,et al. PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer , 2015, Cell.
[129] M. Haas,et al. A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients , 2015, Transplantation.
[130] L. Gesualdo,et al. Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma , 2014, Medicine.
[131] A. Tenner,et al. Complement modulation of T cell immune responses during homeostasis and disease , 2014, Journal of leukocyte biology.
[132] Wuding Zhou,et al. Mannan‐binding lectin‐associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4 , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[133] C. Tripodo,et al. Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice , 2014, Leukemia.
[134] Loreto Gesualdo,et al. A Single-Center Cohort Study to Define the Role of Pretransplant Biopsy Score in the Long-term Outcome of Kidney Transplantation , 2014, Transplantation.
[135] L. Gesualdo,et al. Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[136] Ming-hui Zhao,et al. The Alternative Pathway of Complement Activation May Be Involved in the Renal Damage of Human Anti-Glomerular Basement Membrane Disease , 2014, PloS one.
[137] K. Baggerly,et al. Autocrine Effects of Tumor-Derived Complement , 2014, Cell reports.
[138] K. Wood,et al. Induction of transplantation tolerance through regulatory cells: from mice to men , 2014, Immunological reviews.
[139] L. Gesualdo,et al. Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma , 2014, Disease markers.
[140] D. G. Sandor,et al. The role of complement in membranous nephropathy. , 2013, Seminars in nephrology.
[141] C. Legendre,et al. Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. , 2013, Transplantation reviews.
[142] Jie Gu,et al. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer. , 2013, Lung cancer.
[143] L. Rostaing,et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[144] J. Lindeman,et al. Acute But Transient Release of Terminal Complement Complex After Reperfusion in Clinical Kidney Transplantation , 2013, Transplantation.
[145] Feng Yu,et al. Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis. , 2012, Rheumatology.
[146] L. Domański,et al. Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[147] G. Remuzzi,et al. STEC-HUS, atypical HUS and TTP are all diseases of complement activation , 2012, Nature Reviews Nephrology.
[148] John D Lambris,et al. Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization. , 2012, Neoplasia.
[149] P. Handford,et al. The CD46 and Jagged1 interaction is critical for human T helper 1 immunity , 2012, Nature Immunology.
[150] M. Carroll,et al. Regulation of humoral immunity by complement. , 2012, Immunity.
[151] P. Morgado,et al. Complement Protein C1q Directs Macrophage Polarization and Limits Inflammasome Activity during the Uptake of Apoptotic Cells , 2012, The Journal of Immunology.
[152] M. Stegall,et al. Terminal Complement Inhibition Decreases Antibody‐Mediated Rejection in Sensitized Renal Transplant Recipients , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[153] Jinhua Lu,et al. C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. , 2011, Molecular immunology.
[154] Kenneth C. Anderson,et al. Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors , 2011, The Journal of Immunology.
[155] M. Sughrue,et al. Cancer and the Complement Cascade , 2010, Molecular Cancer Research.
[156] John D Lambris,et al. Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.
[157] P. Ditonno,et al. Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years. , 2010, Transplantation proceedings.
[158] M. Daha,et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. , 2010, The American journal of pathology.
[159] F. Casagrande,et al. In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma , 2009, British Journal of Cancer.
[160] D. Lambrechts,et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. , 2009, The New England journal of medicine.
[161] John D. Lambris,et al. Modulation of the anti-tumor immune response by complement , 2008, Nature Immunology.
[162] P. Heeger,et al. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. , 2008, Blood.
[163] G. Dubyak,et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. , 2008, Immunity.
[164] B. Boudailliez,et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. , 2007, Journal of the American Society of Nephrology : JASN.
[165] A. Jevnikar,et al. Preventing Renal Ischemia–Reperfusion Injury Using Small Interfering RNA by Targeting Complement 3 Gene , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[166] W. Fridman,et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome , 2004, Journal of Medical Genetics.
[167] M. Nangaku,et al. Critical Protection from Renal Ischemia Reperfusion Injury by CD55 and CD591 , 2004, The Journal of Immunology.
[168] G. Remuzzi,et al. Familial haemolytic uraemic syndrome and an MCP mutation , 2003, The Lancet.
[169] M. Walport,et al. Complement. Second of two parts. , 2001, The New England journal of medicine.
[170] M. Walport. Complement. First of two parts. , 2001, The New England journal of medicine.
[171] D. Pérez-Caballero,et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. , 2001, American journal of human genetics.
[172] B. Julian,et al. Complement activation in IgA nephropathy. , 1987, Kidney international.
[173] H. Coovadia,et al. C3 metabolism in acute glomerulonephritis: implications for sites of complement activation. , 1984, Kidney international.
[174] G. Remuzzi,et al. Kidney diseases , 1913, Immunological reviews.
[175] Handbook of Cancer and Immunology , 2022 .
[176] T. Freiwald,et al. Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics. , 2021, Advances in immunology.
[177] M. Presta,et al. Long pentraxin 3: A novel multifaceted player in cancer. , 2018, Biochimica et biophysica acta. Reviews on cancer.
[178] M. Kirschfink,et al. The complement system in cancer: Ambivalence between tumour destruction and promotion. , 2017, Immunobiology.
[179] L. Gesualdo,et al. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population , 2014, World Journal of Urology.
[180] B. Ranchin,et al. C3 nephritic factor associated with C3 glomerulopathy in children , 2013, Pediatric Nephrology.
[181] P. Ditonno,et al. Obesity in kidney transplantation affects renal function but not graft and patient survival. , 2011, Transplantation proceedings.